RECURRENT EPENDYMOMA

Clinical trials for RECURRENT EPENDYMOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT EPENDYMOMA trials appear

Sign up with your email to follow new studies for RECURRENT EPENDYMOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 8 Completed 2

New hope for kids with deadly brain tumors: experimental drug ONC206 enters human testing

Disease control Recruiting now

This study tests an experimental drug called ONC206, alone or with radiation, in children and young adults with a rare and aggressive brain tumor called diffuse midline glioma (DMG) or other recurring brain cancers. The goal is to find the best dose and see if it is safe. ONC206 …

Matched conditions: RECURRENT EPENDYMOMA

Phase: PHASE1 • Sponsor: Sabine Mueller, MD, PhD • Aim: Disease control

Last updated May 01, 2026 15:58 UTC

RECURRENT EPENDYMOMA

Get alerted when new RECURRENT EPENDYMOMA trials appear

New hope for kids with deadly brain tumors: experimental drug ONC206 enters human testing